Ben Byrne

1.4k total citations
35 papers, 437 citations indexed

About

Ben Byrne is a scholar working on Surgery, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Ben Byrne has authored 35 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 12 papers in Oncology and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Ben Byrne's work include Cardiac, Anesthesia and Surgical Outcomes (7 papers), Lymphoma Diagnosis and Treatment (7 papers) and CAR-T cell therapy research (5 papers). Ben Byrne is often cited by papers focused on Cardiac, Anesthesia and Surgical Outcomes (7 papers), Lymphoma Diagnosis and Treatment (7 papers) and CAR-T cell therapy research (5 papers). Ben Byrne collaborates with scholars based in United Kingdom, United States and Switzerland. Ben Byrne's co-authors include Charles Vincent, Omar Faiz, Ravikrishna Mamidanna, Thanos Athanasiou, Samuel Pannick, Rachel Davis, Hutan Ashrafian, Iain Beveridge, Nick Sevdalis and Robert M. Wachter and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Surgery.

In The Last Decade

Ben Byrne

32 papers receiving 426 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ben Byrne United Kingdom 12 140 112 80 68 66 35 437
Maria Eberlein-Gonska Germany 13 68 0.5× 115 1.0× 99 1.2× 56 0.8× 104 1.6× 50 558
Divya Gupta United States 11 129 0.9× 90 0.8× 81 1.0× 100 1.5× 55 0.8× 41 575
Aswin Kumar India 12 231 1.6× 228 2.0× 42 0.5× 30 0.4× 73 1.1× 52 573
Viktor Chirikov United States 14 66 0.5× 54 0.5× 63 0.8× 32 0.5× 37 0.6× 59 482
Megan Delisle Canada 14 122 0.9× 224 2.0× 51 0.6× 133 2.0× 95 1.4× 37 536
Karen Devon Canada 13 119 0.8× 209 1.9× 102 1.3× 58 0.9× 52 0.8× 31 531
Nikhil K. Mull United States 9 76 0.5× 69 0.6× 81 1.0× 31 0.5× 57 0.9× 22 437
Mickaël Basson France 5 142 1.0× 101 0.9× 33 0.4× 50 0.7× 37 0.6× 6 527
Sébastien Lamy France 13 111 0.8× 91 0.8× 103 1.3× 32 0.5× 95 1.4× 60 507
Shelby D. Reed United States 10 57 0.4× 64 0.6× 137 1.7× 56 0.8× 50 0.8× 14 604

Countries citing papers authored by Ben Byrne

Since Specialization
Citations

This map shows the geographic impact of Ben Byrne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ben Byrne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ben Byrne more than expected).

Fields of papers citing papers by Ben Byrne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ben Byrne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ben Byrne. The network helps show where Ben Byrne may publish in the future.

Co-authorship network of co-authors of Ben Byrne

This figure shows the co-authorship network connecting the top 25 collaborators of Ben Byrne. A scholar is included among the top collaborators of Ben Byrne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ben Byrne. Ben Byrne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Phillips, Tycel, Carmelo Carlo‐Stella, Franck Morschhauser, et al.. (2024). Glofitamab monotherapy in patients with heavily pretreated relapsed/refractory (R/R) mantle cell lymphoma (MCL): Updated analysis from a phase I/II study.. Journal of Clinical Oncology. 42(16_suppl). 7008–7008. 7 indexed citations
2.
Phillips, Tycel, Carmelo Carlo‐Stella, Franck Morschhauser, et al.. (2024). Glofitamab in Relapsed/Refractory Mantle Cell Lymphoma: Results From a Phase I/II Study. Journal of Clinical Oncology. 43(3). 318–328. 18 indexed citations
3.
Phillips, Tycel, Matthew J. Matasar, Toby A. Eyre, et al.. (2024). MCL-339 GLOBRYTE: A Phase III, Open-label Multicenter, Randomized Trial Evaluating Glofitamab Monotherapy in Patients with Relapsed or Refractory Mantle Cell Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 24. S515–S515. 1 indexed citations
4.
Byrne, Ben, Jervoise Andreyev, Jason Dunn, et al.. (2023). OGC P28 Gastrointestinal symptoms and disorders after oesophago-gastric cancer surgery: The RESTORE modified Delphi survey. British journal of surgery. 110(Supplement_8).
5.
Carlo‐Stella, Carmelo, Martin Hutchings, Fritz Offner, et al.. (2023). GLOFITAMAB MONOTHERAPY INDUCES DURABLE COMPLETE REMISSIONS AND HAS A MANAGEABLE SAFETY PROFILE IN PATIENTS WITH RICHTER’S TRANSFORMATION. Hematological Oncology. 41(S2). 63–65. 12 indexed citations
6.
Phillips, Tycel, Michael Dickinson, Franck Morschhauser, et al.. (2023). MCL-467 Glofitamab Monotherapy Induces High Complete Response Rates in Patients With Heavily Pretreated Relapsed or Refractory Mantle Cell Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 23. S462–S462. 2 indexed citations
7.
Pucher, Philip H., Annie E. Coombes, J. Moore, et al.. (2022). Patient perspectives on key symptoms and preferences for follow-up after upper gastro-intestinal cancer surgery. Supportive Care in Cancer. 30(6). 5269–5275. 1 indexed citations
8.
Main, Barry, Natalie Blencowe, Sian Cousins, et al.. (2018). Protocol for the systematic review of the reporting of transoral robotic surgery. BMJ Open. 8(1). e019198–e019198. 5 indexed citations
11.
Byrne, Ben & Stephen Case. (2016). Towards a positive youth justice. Safer Communities. 15(2). 69–81. 15 indexed citations
12.
Byrne, Ben, Anna Pinto, Paul Aylin, et al.. (2015). Understanding how colorectal units achieve short length of stay: an interview survey among representative hospitals in England. Patient Safety in Surgery. 9(1). 2–2. 2 indexed citations
13.
Pannick, Samuel, Rachel Davis, Hutan Ashrafian, et al.. (2015). Effects of Interdisciplinary Team Care Interventions on General Medical Wards. JAMA Internal Medicine. 175(8). 1288–1288. 86 indexed citations
14.
Byrne, Ben, Omar Faiz, & Charles Vincent. (2015). Do patients with gastrointestinal cancer want to decide where they have tests and surgery? A questionnaire study of provider choice. BMJ Quality & Safety. 25(9). 696–703. 5 indexed citations
15.
Byrne, Ben, Ravikrishna Mamidanna, Charles Vincent, & Omar Faiz. (2014). Outlier Identification in Colorectal Surgery Should Separate Elective and Nonelective Service Components. Diseases of the Colon & Rectum. 57(9). 1098–1104. 4 indexed citations
16.
Byrne, Ben, Graham Branagan, & H. Chave. (2012). Unselected rectal cancer patients undergoing low anterior resection with defunctioning ileostomy can be safely managed within an Enhanced Recovery Programme. Techniques in Coloproctology. 17(1). 73–78. 6 indexed citations
17.
Byrne, Ben, et al.. (2012). The Axillary Nodal Harvest in Breast Cancer Surgery Is Unchanged by Sentinel Node Biopsy or the Timing of Surgery. International Journal of Breast Cancer. 2012. 1–5. 1 indexed citations
18.
Lanning, Sharon K., et al.. (2012). Evaluation of a Revised Curriculum: A Four‐Year Qualitative Study of Student Perceptions. Journal of Dental Education. 76(10). 1323–1333. 22 indexed citations
19.
Byrne, Ben, Timothy J. Geddes, Fenella K.S. Welsh, et al.. (2011). The incidence and outcome of brain metastases after liver resection for colorectal cancer metastases. Colorectal Disease. 14(6). 721–726. 21 indexed citations
20.
Byrne, Ben, et al.. (2009). Does sentinel node biopsy or the timing of completion axillary clearance alter the axillary nodal harvest in breast cancer surgery?. European Journal of Surgical Oncology. 35(11). 1234–1234. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026